Neuralink has been approved by U.S. regulators for its trial application for human brain implants

Neuralink, an esteemed company under Elon Musk’s patronage, specializing in brain-machine interface technology, has pronounced that it has secured approval from the U.S. regulatory authorities for its proposal to implant microchips into the human brain.

According to Neuralink’s official Twitter announcement, the U.S. Food and Drug Administration has endorsed its application to conduct chip implant trials in human brains, underscoring this as a significant advancement in the field of brain-machine interface technology. However, Neuralink has yet to divulge any specifics regarding the timeline for the human brain chip implant trials.

Prior to this, Neuralink had conducted experimental trials on various animals such as pigs and monkeys. Although the trials were reported successful in pigs, yielding a seamless connection to brain wave information, experiments involving monkeys were marred by numerous fatalities, triggering widespread societal condemnation.

Previous reports suggested that the U.S. Food and Drug Administration harbored concerns over the potential impact on the human body by lithium batteries used in Neuralink’s devices, thus the agency was speculated to reject the application for human trials. However, the latest announcement from Neuralink suggests that they have managed to effectively address these apprehensions.